For the millions of people living with HIV on long-term antiretroviral therapy, the dominant clinical narrative has long equated disclosure with empowerment and silence with shame or denial. That assumption may be fundamentally incomplete — and its persistence could be quietly driving people away from the care systems meant to support them.
A qualitative study conducted in Tamil Nadu, India, explored how 21 long-term ART users — each having maintained treatment for 10 to 22 years — navigate HIV concealment across intimate, familial, and institutional settings. Using analytical frameworks drawn from stigma theory, emotion work, and institutional betrayal, researchers identified four interlocking behavioral patterns: emotional rupture from the original diagnosis, strategic non-disclosure calibrated by relationship and risk, moral reframing often anchored in spiritual meaning-making, and progressive withdrawal from healthcare institutions perceived as confidentiality threats. Crucially, silence divided along gendered lines: women's non-disclosure was oriented around caregiving labor — shielding children, preserving household stability — while men framed concealment as stoic endurance or sacrifice, a form of masculine restraint rather than protection of others.
This work joins a small but growing body of qualitative HIV research challenging the disclosure-as-empowerment orthodoxy, particularly in low- and middle-income contexts where institutional trust is fragile and stigma structurally embedded. The finding that long-term survivors actively withdraw from stigmatizing care environments — rather than passively dropping out — reframes retention failures as rational responses to systemic harm, with real implications for treatment adherence modeling. Key limitations include the small purposive sample and single-state Indian context, making generalizability uncertain. Yet the four-pattern framework offers a clinically actionable lens. The call to depathologize silence and redesign counseling around dignity rather than disclosure compliance represents an incremental but meaningfully directional shift for HIV care delivery globally.
